Bayesian methods for analysis of binary outcome data in cluster randomized trials on the absolute risk scale

Statistics in Medicine

Volumn 23, Issue 3, 2004, Pages 389-410

  Thompson, Simon G ^a   Warn, David E ^a   Turner, Rebecca M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Absolute risk scale; Bayesian methods; Binary data; Cluster randomized trials

Indexed keywords

ARTICLE; BAYES THEOREM; CLINICAL STUDY; CLINICAL TRIAL; CLUSTER ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY RISK; COVARIANCE; HUMAN; INFORMATION PROCESSING; ISCHEMIC HEART DISEASE; OUTCOMES RESEARCH; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SECONDARY PREVENTION; STATISTICAL ANALYSIS; STATISTICAL DISTRIBUTION; STATISTICAL MODEL;

BAYES THEOREM; CLUSTER ANALYSIS; HUMANS; MODELS, STATISTICAL; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS; RISK;

EID: 0842281904     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.1567     Document Type: Article

References (38)

1. Donner A, Klar N. Design and Analysis of Cluster Randomization Trials in Health Research. Arnold: New York, 2000.
2. Torgerson DJ. Contamination in trials: is cluster randomisation the answer? British Medical Journal 2001; 322:355-357.
3. Sullivan LM, Dukes KA, Losina E. An introduction to hierarchical linear modelling. Statistics in Medicine 1999; 18:855-888.
4. Omar RZ, Thompson SG. Analysis of a cluster randomized trial with binary outcome data using a multi-level model. Statistics in Medicine 2000; 19:2675-2688.
5. Spiegelhalter DJ. Bayesian methods for cluster randomized trials with continuous responses. Statistics in Medicine 2001; 20:435-452.
6. Turner RM, Omar RZ, Thompson SG. Bayesian methods of analysis for cluster randomized trials with binary outcome data. Statistics in Medicine 2001; 20:453-472.
7. Sackett DL, Deeks JJ, Altman DG. Down with odds ratios! Evidence Based Medicine 1996; 1:164-166.
8. Sinclair JC, Bracken MB. Clinically useful measures of effect in binary analysis of randomized trials. Journal of Clinical Epidemiology 1994; 47:81-90.
9. Deeks JJ. Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes. Statistics in Medicine 2002; 20:1575-1600.
10. Walter SD. Choice of effect measure for epidemiological data. Journal of Clinical Epidemiology 2000; 53: 931-939.
11. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. New England Journal of Medicine 1988; 318:1728-1733.
12. Moher M, Yudkin P, Wright L, Turner R, Fuller A, Schofield T, Mant D. Cluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary heart disease in primary care. British Medical Journal 2001; 322:1338-1342.
13. Jolly K, Bradley F, Sharp S, Smith H, Thompson S, Kinmouth A-L, Mant D. Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: final results of Southampton heart integrated care project (SHIP). British Medical Journal 1999; 318:706-711.
14. Warn DE, Thompson SG, Spiegelhalter DJ. Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales. Statistics in Medicine 2002; 20:1601-1623.
15. Commenges D, Jacqmin H. The intraclass correlation coefficient: distribution-free definition and test. Biometrics 1994; 50:517-526.
16. Gilks WR, Thomas A, Spiegelhalter DJ. A language and program for complex Bayesian modelling. Statistician 1994; 43:169-177.
17. Gelman A, Rubin DB. A single series from the Gibbs Sampler provides a false sense of security. In Bayesian Statistics 4, Bernando JM, Berger JO, Dawid AP, Smith AFM (eds). Oxford University Press: 1992; 625-631.
18. Geweke J. Evaluating the accuracy of sampling-based approaches to calculating posterior moments. In Bayesian Statistics 4, Bernando JM, Berger JO, Dawid AP, Smith AFM (eds). Oxford University Press: 1992; 169-193.
19. Raftery AE, Lewis SM. How many iterations in the Gibbs sampler? In Bayesian Statistics 4, Bernando JM, Berger JO, Dawid AP, Smith AFM (eds). Oxford University Press: 1992; 763-775.
20. Goldstein H, Rasbach J, Plewis I, Draper D, Browne W, Yang M, Woodhouse G, Healy MJR. A User's Guide to MLwiN. Institute of Education: London, 1998.
21. Turner RM, Omar RZ, Yang M, Goldstein H, Thompson SG. A multilevel framework for meta-analysis of clinical trials with binary outcomes. Statistics in Medicine 2000; 19:3417-3432.
22. Ukoumunne OC, Gulliford MC, Chinn S, Sterne JAC, Burney PGJ. Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review. Health Technology Assessment 1999; 3.
23. Campbell M, Grimshaw J, Steen N. Sample size calculations for cluster randomised trials. Journal of Health Services Research and Policy 2000; 5:12-16.
24. Swiger LA, Harvey LR, Everson DO, Gregory KE. The variance of intraclass correlation involving groups with one observation. Biometrics 1964; 20:818-826.
25. Hill WG, Smith C. Estimating 'heritability' of a dichotomous trait. Biometrics 1977; 33:234-236.
26. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. British Medical Journal 1995; 310:452-454.
27. Kristiansen IS, Gyrd-Hansen D, Nexoe J, Nielsen JB. Number needed to treat: easily understood and intuitively meaningful? Theoretical considerations and a randomized trial. Journal of Clinical Epidemiology 2002; 55: 888-892.
28. Altman DG. Confidence intervals for the number needed to treat. British Medical Journal 1998; 317:1309-1312.
29. Hutton JL. Number needed to treat: properties and problems. Journal of the Royal Statistical Society, Series A 2000; 163:403-419.
30. Spiegelhalter DJ, Best NG, Carlin BP, van der Linde A. Bayesian measures of complexity and fit. Journal of the Royal Statistical Society, Series B 2002; 64:1-34.
31. Thompson SG, Pyke SDM, Hardy RJ. The design and analysis of paired cluster randomised trials: an application of meta-analysis techniques. Statistics in Medicine 1997; 16:2063-2079.
32. Feldman HA, McKinlay SM. Cohort versus cross-sectional design in large field trials: precision, sample size, and a unifying model. Statistics in Medicine 1994; 13:61-78.
33. Ukoumunne OC, Thompson SG. Analysis of cluster randomised trials with repeated binary cross-sectional measurements. Statistics in Medicine 2001; 20:417-433.
34. Hu FB, Goldberg J, Hedeker D, Flay BR, Pentz MA. Comparison of population-averaged and subject specific approaches for analyzing repeated binary outcomes. American Journal of Epidemiology 1998; 147:694-703.
35. Neuhaus JM. Statistical methods for longitudinal and clustered designs with binary responses. Statistical Methods in Medical Research 1992; 1:249-273.
36. Klar N, Donner A. Current and future challenges in the design and analysis of cluster randomization trials. Statistics in Medicine 2001; 20:3729-3740.
37. Murray DM. Design and Analysis of Group-randomized Trials. Oxford University Press: New York, 1998.
38. Donner A. Some aspects of the design and analysis of cluster randomization trials. Applied Statistics 1998; 47:95-113.